Our studies and others have indicated that the expression of PC4 is upregulated in various cancers, including lung cancer, breast cancer, prostate cancer, astrocytoma, and esophageal squamous cell carcinoma, and that PC4 drives cancer development and progression (25, 29, 30, 31, 32). Here, SUB1 is linked to esophageal squamous cell carcinoma.